SCHEMBL14367272

SCHEMBL14367272

CC(C)[C@H](N)c1nc2ncccc2c(=O)n1Cc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 3/20 0.57
PDE4B Q07343 3/20 0.57
PDE4C Q08493 3/20 0.57
PDE4D Q08499 3/20 0.57
KIF11 P52732 1/20 0.51
RXFP1 Q9HBX9 1/20 0.47
RAB9A P51151 2/20 0.43
POLB P06746 1/20 0.43
MAPT P10636 2/20 0.43
KDM4E B2RXH2 2/20 0.43
GAA P10253 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
BRD4 O60885 2/20 0.43
ALDH1A1 P00352 2/20 0.42
LMNA P02545 1/20 0.42
RECQL P46063 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
PTGDR2 Q9Y5Y4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14522636 1.00 PDE4A (0.57) PDE4APDE4BPDE4CPDE4DKIF11
SCHEMBL14367276 0.86 PDE4A (0.57) PDE4APDE4BPDE4CPDE4DKIF11
SCHEMBL14522639 0.86 PDE4A (0.57) PDE4APDE4BPDE4CPDE4DKIF11
SCHEMBL5116695 0.86 KIF11 (0.51) PDE4APDE4BPDE4CPDE4DKIF11
SCHEMBL5561425 0.81 PDE4A (0.60) PDE4APDE4BPDE4CPDE4DKIF11
SCHEMBL4102537 0.81 MAPT (0.45) PDE4APDE4BPDE4CPDE4DKIF11
SCHEMBL5118303 0.80 ALDH1A1 (0.43) PDE4APDE4BPDE4CPDE4DKIF11
SCHEMBL5489353 0.79 ALDH1A1 (0.45) PDE4APDE4BPDE4CPDE4DKIF11
SCHEMBL5120055 0.78 KIF11 (0.39) PDE4APDE4BPDE4CPDE4DKIF11
SCHEMBL14367275 0.78 PDE4A (0.69) PDE4APDE4BPDE4CPDE4DKIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070254870-A1 Compounds, compositions and methods CYTOKINETICS, INC. 2007-11-01 US disclosed
US-20070254870-A1 Compounds, compositions and methods CYTOKINETICS, INC. 2007-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070254870-A1 Compounds, compositions and methods ALPP, PCNA, MKI67 PDE4A 3029/4885PDE4B 3016/4885PDE4C 2753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.